医院规模与心力衰竭患者诊疗过程及结局的关系:来自GWTG-HF的启示
结果显示低容量医院对心衰过程指标依从性显著更低;高容量与院内死亡、30天死亡或再入院无显著关联,仅与6个月死亡和再入院呈弱关联。作者建议医院评价应关注系统参与、过程依从性和风险标化结局而非医院规模本身。
要点
- 低容量医院对心衰诊疗过程指标的依从性显著低于高容量医院。
- 医院容量与院内死亡、30天死亡或再入院无显著关联。
- 高容量仅与6个月死亡和再入院呈弱关联,临床意义有限。
核心结论
- 医院容量作为结构指标与心衰诊疗过程指标相关,但与30天结局无关,仅与6个月结局有微弱关联。
- 医院评价应聚焦于参与系统化诊疗、过程指标依从性及风险标化结局,而非医院容量本身。
研究设计与样本
- 研究为GWTG-HF注册与Medicare住院数据链接的回顾性队列分析,覆盖342家医院。
- 采用校正logistic回归和Cox比例风险模型分析医院容量与过程指标及结局的关联。
主要发现
- 高容量医院收治的患者合并症负担更高。
- 多变量模型显示低容量医院对心衰过程指标的依从性显著低于高容量医院。
- 高容量与院内死亡无显著关联(OR 0.99,95%CI 0.94-1.05,P=0.78)。
- 高容量与30天死亡(HR 0.99,95%CI 0.97-1.01,P=0.26)及30天再入院(HR 0.99,95%CI 0.97-1.00,P=0.10)均无显著关联。
- 高容量与6个月死亡(HR 0.98,95%CI 0.97-0.99,P=0.001)及6个月全因再入院(HR 0.98,95%CI 0.97-1.00,P=0.025)呈弱关联。
临床怎么用
- 心衰诊疗质量改进应优先关注过程指标依从性,而非医院年病例量。
- 低容量医院需加强心衰诊疗流程的标准化和系统参与。
- 医院绩效评价宜采用风险标化结局和过程指标,避免单纯以容量排名。
局限性
- 研究为观察性设计,可能存在未测量混杂。
- 样本为参与GWTG-HF注册的医院及Medicare老年患者,外推性受限。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hospital volume is frequently used as a structural metric for assessing quality of care, but its utility in patients admitted with acute heart failure (HF) is not well characterized. Accordingly, we sought to determine the relationship between admission volume, process-of-care metrics, and short- and long-term outcomes in patients admitted with acute HF. METHODS: Patients enrolled in the Get With The Guidelines-HF registry with linked Medicare inpatient data at 342 hospitals were assessed. Volume was assessed both as a continuous variable, and quartiles based on the admitting hospital annual HF case volume, as well: 5 to 38 (quartile 1), 39 to 77 (quartile 2), 78 to 122 (quartile 3), 123 to 457 (quartile 4). The main outcome measures were (1) process measures at discharge (achievement of HF achievement, quality, reporting, and composite metrics); (2) 30-day mortality and hospital readmission; and (3) 6-month mortality and hospital readmission. Adjusted logistic and Cox proportional hazards models were used to study these associations with hospital volume. RESULTS: A total of 125 595 patients with HF were included. Patients admitted to high-volume hospitals had a higher burden of comorbidities. On multivariable modeling, lower-volume hospitals were significantly less likely to be adherent to HF process measures than higher-volume hospitals. Higher hospital volume was not associated with a difference in in-hospital (odds ratio, 0.99; 95% confidence interval [CI], 0.94-1.05; P=0.78) or 30-day mortality (hazard ratio, 0.99; 95% CI, 0.97-1.01; P=0.26), or 30-day readmissions (hazard ratio, 0.99; 95% CI, 0.97-1.00; P=0.10). There was a weak association of higher volumes with lower 6-month mortality (hazard ratio, 0.98; 95% CI, 0.97-0.99; P=0.001) and lower 6-month all-cause readmissions (hazard ratio, 0.98; 95%, CI 0.97-1.00; P=0.025). CONCLUSIONS: Our analysis of a large contemporary prospective national quality improvement registry of older patients with HF indicates that hospital volume as a structural metric correlates with process measures, but not with 30-day outcomes, and only marginally with outcomes up to 6 months of follow-up. Hospital profiling should focus on participation in systems of care, adherence to process metrics, and risk-standardized outcomes rather than on hospital volume itself.
引用
- Kumbhani DJ, Fonarow GC, Heidenreich PA, et al. Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure. Circulation. 2018. PMID: 29378692. doi:10.1161/CIRCULATIONAHA.117.028077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。